A new trading day began on Friday, with Skye Bioscience Inc (NASDAQ: SKYE) stock price up 19.05% from the previous day of trading, before settling in for the closing price of $1.89. SKYE’s price has ranged from $1.83 to $17.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -64.38%. With a float of $17.57 million, this company’s outstanding shares have now reached $30.97 million.
The extent of productivity of a business whose workforce counts for 16 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Skye Bioscience Inc (SKYE) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Skye Bioscience Inc is 42.09%, while institutional ownership is 43.95%. The most recent insider transaction that took place on Nov 18 ’24, was worth 97,250. In this transaction Chief Development Officer of this company sold 19,489 shares at a rate of $4.99, taking the stock ownership to the 82,259 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Development Officer sold 85 for $5.55, making the entire transaction worth $472. This insider now owns 101,748 shares in total.
Skye Bioscience Inc (SKYE) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -64.38% per share during the next fiscal year.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
Here are Skye Bioscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.43 in one year’s time.
Technical Analysis of Skye Bioscience Inc (SKYE)
The latest stats from [Skye Bioscience Inc, SKYE] show that its last 5-days average volume of 0.35 million was superior to 0.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 21.01%. Additionally, its Average True Range was 0.30.
During the past 100 days, Skye Bioscience Inc’s (SKYE) raw stochastic average was set at 10.28%, which indicates a significant decrease from 40.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 126.00% in the past 14 days, which was higher than the 101.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.79, while its 200-day Moving Average is $4.75. Now, the first resistance to watch is $2.42. This is followed by the second major resistance level at $2.58. The third major resistance level sits at $2.84. If the price goes on to break the first support level at $2.00, it is likely to go to the next support level at $1.74. Assuming the price breaks the second support level, the third support level stands at $1.58.
Skye Bioscience Inc (NASDAQ: SKYE) Key Stats
With a market capitalization of 68.26 million, the company has a total of 30,338K Shares Outstanding. Currently, annual sales are 0 K while annual income is -37,640 K. The company’s previous quarter sales were 0 K while its latest quarter income was -3,900 K.
